AU3108800A - Era complexes and uses thereof - Google Patents

Era complexes and uses thereof

Info

Publication number
AU3108800A
AU3108800A AU31088/00A AU3108800A AU3108800A AU 3108800 A AU3108800 A AU 3108800A AU 31088/00 A AU31088/00 A AU 31088/00A AU 3108800 A AU3108800 A AU 3108800A AU 3108800 A AU3108800 A AU 3108800A
Authority
AU
Australia
Prior art keywords
era
complexes
era complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31088/00A
Inventor
Stanley Richard Jaskunas Jr.
Timothy Ivan Meier
Robert Brown Peery
Genshi Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU3108800A publication Critical patent/AU3108800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU31088/00A 1998-12-04 1999-12-03 Era complexes and uses thereof Abandoned AU3108800A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US11091298P 1998-12-04 1998-12-04
US60110912 1998-12-04
US14836299P 1999-08-11 1999-08-11
US60148362 1999-08-11
US14891499P 1999-08-13 1999-08-13
US60148914 1999-08-13
PCT/US1999/028642 WO2000034316A1 (en) 1998-12-04 1999-12-03 Era complexes and uses thereof

Publications (1)

Publication Number Publication Date
AU3108800A true AU3108800A (en) 2000-06-26

Family

ID=27380927

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31088/00A Abandoned AU3108800A (en) 1998-12-04 1999-12-03 Era complexes and uses thereof

Country Status (2)

Country Link
AU (1) AU3108800A (en)
WO (1) WO2000034316A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165989A (en) * 1996-05-14 2000-12-26 Smithkline Beecham Corporation Era of Streptococcus pneumoniae

Also Published As

Publication number Publication date
WO2000034316A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
AU4208799A (en) Interleukins-21 and 22
AU7223798A (en) Particle manipulation
AU9790198A (en) Compounds and methods
AU3485999A (en) Neo-tryptophan
AU4161899A (en) Radiotherapeutical device and use thereof
AU9781998A (en) Huchordin and uses thereof
AU4198299A (en) Compounds and uses thereof
AU3753599A (en) Micro-compartmentalization device and uses thereof
AU5970699A (en) Use
AU6513299A (en) 3x adder
AU7073800A (en) Novel plexins and uses thereof
AUPP433398A0 (en) Compounds and processes
AU2841801A (en) Triazolotriazinones and the use thereof
AU3522399A (en) Carvedilol-galenics
AU2701799A (en) Computers
AU8695298A (en) Compounds and uses thereof
AU3253699A (en) Myxochelines
AU2333099A (en) Aryloxyanilides and related compounds
AU9650398A (en) Piperazine-cyclodextrin complexes
AU5979300A (en) Angiopoietin-6 and uses thereof
AU3086200A (en) Eyesight-correction and/or eye-training device
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU8693198A (en) Compounds and uses thereof
AU1055399A (en) Rollerboard

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase